Skip to content
MediHelp
MediHelp Drug reference

Drug interactions

Abiraterone + Metoclopramide intranasal

Severity: Major

Abiraterone and Metoclopramide intranasal: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Abiraterone inhibits CYP2D6 and may increase metoclopramide exposure, raising the risk of extrapyramidal symptoms and tardive dyskinesia.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Abiraterone and Metoclopramide intranasal interact, what to do about it, and the sources.

  • Mechanism of action
  • Clinical management
  • Evidence level
Create free account Sign in

Free 14-day trial. No card needed.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

App Store Google Play

Browse A–Z · Drug interactions